Al-Hendy Lab Publications
The Al-Hendy lab is highly active in publishing their research findings to advance scientific and clinical knowledge. Please review some of the lab's featured articles below:
Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Am J Obstet Gynecol. 2022 Nov 9:S0002-9378(22)02166-4. doi: 10.1016/j.ajog.2022.11.1278. Epub ahead of print. PMID: 36370871 |
Chugh RM, Park HS, Esfandyari S, Elsharoud A, Ulin M, Al-Hendy A. Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2. Int J Mol Sci. 2021 Aug 25;22(17):9184. doi: 10.3390/ijms22179184. PMID: 34502090 |
Chugh RM, Park HS, El Andaloussi A, Elsharoud A, Esfandyari S, Ulin M, Bakir L, Aboalsoud A, Ali M, Ashour D, Igboeli P, Ismail N, McAllister J, Al-Hendy A. Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Stem Cell Res Ther. 2021 Jul 7;12(1):388. doi: 10.1186/s13287-021-02472-w. PMID: 34233746 |
Park HS, Chugh RM, El Andaloussi A, Hobeika E, Esfandyari S, Elsharoud A, Ulin M, Garcia N, Bilal M, Al-Hendy A. Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model. Sci Rep. 2021 Feb 25;11(1):4525. doi: 10.1038/s41598-021-84216-7. PMID: 33633319 |
Esfandyari S, Elkafas H, Chugh RM, Park HS, Navarro A, Al-Hendy A. Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy. Int J Mol Sci. 2021 Feb 22;22(4):2165. doi: 10.3390/ijms22042165. PMID: 33671587 |
Park HS, Chugh RM, Elsharoud A, Ulin M, Esfandyari S, Aboalsoud A, Bakir L, Al-Hendy A. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model. Cell Transplant. 2021 Jan-Dec;30:963689720988502. doi: 10.1177/0963689720988502. PMID: 33593078 |
Esfandyari S, Chugh RM, Park HS, Hobeika E, Ulin M, Al-Hendy A. Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility. Cells. 2020 Oct 8;9(10):2253. doi: 10.3390/cells9102253. PMID: 33050021 |
Yang Q, Ciebiera M, Victoria Bariani M, Ali M, Elkafas H, Boyer TG, Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2021 Nov 6:bnab039. doi: 10.1210/endrev/bnab039. Epub ahead of print. PMID: 34741454 |
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283. PMID: 33596357 |
View a complete list of Al-Hendy lab publications here.
Media
- Uterine Fibroids and Endometriosis (podcast), Episode 3
- Obstetrics & Gynecology Podcast, Editor's Pick (relugolix + LIBERTY trials)
- Extinguishing the Fireballs
- The Fibroid Project
- A simplified method for removal of wandering Nexplanon implants
- ICG Imaging of Uterine Leiomyoma (Fibroids)
- Red Alert: The Fight Against Fibroids